Ogene Systems India Limited - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U72200TG2004PLC044250 Incorporated 23 September 2004 ROC Hyderabad HQ Hyderabad, Telangana, India
Dissolved Under Section 54 Public Limited Company pharma
Revenue · FY 2020
₹3.73 Cr
▼ 94% YoY
Net loss · FY 2020
₹1.24 Cr
Net margin -33.4%
EBITDA · FY 2020
-₹1.22 Cr
EBITDA margin -32.6%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹24.93 Cr
Issued & subscribed
Satisfied charges
₹85.73 Cr
No open charges
Company age
22 yrs
Est. 2004
Employees · EPFO
13
Provident fund records

About Ogene Systems India Limited

Data last updated:

Ogene Systems India Limited was a public limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Swain Finance And Trading Private Limited. The company has been dissolved under section 54 as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 September 2004.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG2004PLC044250. Its GSTIN is 36AAACO7056R1ZS (Telangana). The company held 3 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.93 Cr. It was formerly known as Ogene Systems India Private Limited. It was led by directors including Rayaprolu Prabhakar Sreenivas and Krishna Reddy Bellanagari.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at H.No.8 – 3 – 191 – 14 Housing Board No.5/A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038.

As per the financials filed for FY 2020, the company reported a revenue of ₹3.73 Cr, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹1.24 Cr (net margin -33.4%) and EBITDA of -₹1.22 Cr (EBITDA margin -32.6%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 41% over five years.

The company had about 13 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: Ogene. As per MCA filings, the company had satisfied charges of ₹85.73 Cr on record. Court records list 12 cases involving the company, including 2 filed by the company and 10 filed against it.

The last known website on record is ogene.co.in.

Company details

CIN U72200TG2004PLC044250
Registration Number 044250
Incorporation Date 23 September 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Dissolved Under Section 54
Parent Company Swain Finance And Trading Private Limited
Compliance Status Active Compliant

CIN history

Ogene Systems India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U72200TG2004PLC044250, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U72200TG2004PLC044250Current
U72200AP2004PLC044250Previous
U72200AP2004PTC044250Previous

Contact details

Ogene Systems India Limited's registered office is in Hyderabad, Telangana. Its website is ogene.co.in. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No.8 – 3 – 191 – 14 Housing Board No.5/A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Ogene Systems India Limited, buy the company report.

Comprehensive company report
Ogene Systems India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Ogene Systems India operates one associated brand: Ogene. Each brand links to its own profile.

BrandDescriptionWebsite
Provides contract research and development services in nanomedicine and radiolabeled products.ogene.co.in

Business activity

The main business activity of Ogene Systems India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ogene Systems India Limited, buy the company report.

Financials of Ogene Systems India Limited

FY 2020 filings available

Ogene Systems India Limited reported revenue of ₹3.73 Cr (down 94% YoY) for FY 2020.

Revenue · FY 2020
₹3.73 Cr ▼ 94%
Net loss · FY 2020
₹1.24 Cr margin -33.4%
EBITDA · FY 2020
-₹1.22 Cr margin -32.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 94%
3 years · compounded
▼ 46%
5 years · compounded
▼ 41%
EBITDA CAGR growth
1 year
▼ 104%
3 years · compounded
▲ 62%

Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 94% fall in the latest year. EBITDA fell 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹3.73 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.22 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.24 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-32.6%
Net Profit Margin-33.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ogene Systems India Limited, buy the company report.

Board of directors of Ogene Systems India Limited

Ogene Systems India has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Rayaprolu Prabhakar SreenivasAdditional Director24 Jul 20206 Years 3 MonthsAs last reported
Krishna Reddy BellanagariAdditional Director04 Nov 20197 Years 0 MonthsAs last reported
Narsimulu KarkaAdditional Director18 Mar 20215 Years 8 MonthsAs last reported

Peer comparison

Ogene Systems India Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sam Laboratories Private Limited₹3.85 Cr (FY 2025)-10.0%Bhavnagar, Gujarat, India
Bizotic Lifescience Private Limited₹3.81 Cr (FY 2024)-72.0%New Kharachiya, Gujarat, India
Shanti Drugs Private Limited₹3.78 Cr (FY 2024)11.0%New Delhi, Delhi, India
Ogene Systems India Limitedthis company₹3.73 Cr (FY 2020)-₹1.24 Cr-33.4%-94.0%13Hyderabad, Telangana, India
Agati Healthcare Private Limited₹3.73 Cr (FY 2024)172.0%Navi Mumbai, Maharashtra, India
Chorus Pharmachem Private Limited₹3.72 Cr (FY 2024)-64.0%Nandesari, Gujarat, India
Athene Chemicals Private Limited₹3.72 Cr (FY 2025)-10.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Ogene Systems India Limited, buy the company report.

Auditor

Ogene Systems India Limited is audited by M G R & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
M G R & COFY 2020012787S

Shareholding

The shareholding of Ogene Systems India Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ogene Systems India Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹85.73 Cr
Breakdown by lending institutions
State Bank of Hyderabad₹51.78 Cr
State Bank of Travancore₹15.25 Cr
Technology Development Board₹13.50 Cr
Reliance Capital Ltd₹3.20 Cr
Punjab National Bank₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Jul 201510585215State Bank of Travancore₹3.75 CrSatisfied
31 May 201410502327Reliance Capital Ltd₹3.2 CrSatisfied
31 May 201010225844State Bank of Travancore₹11.5 CrSatisfied
26 May 201010221753Technology Development Board₹13.5 CrSatisfied
05 Apr 201010214766State Bank of Hyderabad₹51.78 CrSatisfied

To see the full charge records of Ogene Systems India Limited, buy the company report.

Total charge records: 6 View all charges

Credit ratings & regulatory alerts

Ogene Systems India Limited was last rated by Indiarating on 13 Jul 2018.

Rating agencyRated onRating
Indiarating13 Jul 2018

To see the full credit ratings and regulatory alerts of Ogene Systems India Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ogene Systems India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Ogene Systems India Limited has a workforce of 13 employees on its EPFO records as of Apr 2018, across 1 active EPFO establishment.

Employee count
13
Active EPFO establishments
1
Employee growth
-68.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2018-1913
FY 2017-18
FY 2016-17
FY 2015-16

To see the full employee and EPFO history of Ogene Systems India Limited, buy the company report.

GST

Ogene Systems India has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AAACO7056R1ZSTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Ogene Systems India Limited, buy the company report.

Recent activity

Ogene Systems India Limited has 16 board changes on record since 2008: 3 appointments and 13 cessations. The latest: Narsimulu Karka was appointed as Additional Director on 18 Mar 2021.

Appointed
Narsimulu Karka was appointed as Additional Director.
AGM
Ogene Systems India Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Ceased
Balarama Krishnaiah Mandava ceased to be Nominee Director.
Ceased
Gangi Reddy Narravula ceased to be Managing Director.
Appointed
Rayaprolu Prabhakar Sreenivas was appointed as Additional Director.
Filing
Ogene Systems India Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Appointed
Krishna Reddy Bellanagari was appointed as Additional Director.
Ceased
Yellamraju Partha Saradhy ceased to be Director.
Ceased
Anil Inaganti ceased to be Director.
Ceased
Sudhakar Reddy Pesaladinne ceased to be Director.
Ceased
Peranamallur Narayanaswamy Devarajan ceased to be Director.
Charges
A charge registered on 17 Jul 2015 via Charge ID 10585215 with State Bank Of Travancore was fully satisfied on 07 Apr 2018.

21 earlier events are in the company report.

Frequently asked questions

Ogene Systems India has been "Dissolved Under Section 54" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.

Ogene Systems India was a public limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 23 September 2004 and is registered under CIN U72200TG2004PLC044250. The company is recorded as dissolved under section 54 in MCA records and no longer exists as a legal entity.

Ogene Systems India was incorporated on 23 September 2004. It is registered with the Registrar of Companies, Hyderabad.

Ogene Systems India had 3 directors:

The CIN (Corporate Identification Number) of Ogene Systems India is U72200TG2004PLC044250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Ogene Systems India is at H.No.8 – 3 – 191 – 14 Housing Board No.5A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038.

Ogene Systems India can be reached through the website ogene.co.in. Its registered office is in Hyderabad, Telangana, India.

The latest financial statements of Ogene Systems India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Ogene Systems India is 36AAACO7056R1ZS, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

Ogene Systems India operated in the pharma industry, in the api manufacturers segment.

The peers of Ogene Systems India by revenue are Sam Laboratories Private Limited, Bizotic Lifescience Private Limited, Shanti Drugs Private Limited, Agati Healthcare Private Limited, Chorus Pharmachem Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).